MAX LEFTON: Open Payments
NPI 1619452885 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$192 in 10 payments from 9 companies in 2025. Trend: 2023 $30 · 2024 $176 · 2025 $192
Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Daiichi Sankyo Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Tempus AI, Inc | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Janssen Biotech, Inc. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
Products named: Enhertu, CREON, Nubeqa, KEYTRUDA, XT CDX, LIBTAYO, CARVYKTI, ZENPEP.
Industry payments across PA — which companies pay providers there.
